Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03638700
Other study ID # 39/16
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2016
Est. completion date January 2020

Study information

Verified date May 2022
Source Johann Wolfgang Goethe University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In ERCP guidewires are used for the insertion of endoprostheses and the cannulation of stenosis. This leads to two essential requirements for the wire systems: The use of a (highly) flexible, hydrophilic wire to achieve successful and rapid passage of the narrow passage; for additional intervention, modern wires are equipped with a stable shaft with which e.g. bougies, dilatation catheters, or stents can be introduced. Guidewires are available with angled or straight tips whose use differ regionally. Guidewires with angled tips are used predominantly in Japan, whereas in the Western world incl. Germany straight wires are commonly used. In a recently published study examining the intubation of the native papilla, successful intubation of the papilla was faster with guidewires with angled tips than with guidewires with straight tips. However, this did not result in an effect upon the time-independent rate of the successful papilla intubation. The investigators test the hypothesis that 1) a higher success rate of the ERCP can be achieved with the use of an angled guidewire than with a straight guidewire and 2) a higher success rate of the ERCP can be achieved with the use of a type 1 guidewire than with a type 2 guidewire


Description:

This is a randomized, multicentric study.


Recruitment information / eligibility

Status Completed
Enrollment 453
Est. completion date January 2020
Est. primary completion date October 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Obstruction of the biliary tract (cross sectional imaging or ultrasonography/lab data Exclusion Criteria: - Operatively alternated anatomy of the patient

Study Design


Related Conditions & MeSH terms


Intervention

Device:
VisiGlide™ angled tip
Arm A: Primary use of VisiGlide™ guidewire (angled tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide™ (straight tip) resp. to VisiGlid2e™ (tip according to the examiner)
VisiGlide2™ angled tip
Arm B: Primary use of VisiGlide2™ guidewire (angled tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide2™ (straight tip) resp. to VisiGlide™ (tip according to the examiner)
VisiGlide™ straight tip
Arm C: Primary use of VisiGlide™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide™ (angled tip) resp. to VisiGlide2™ (tip according to the examiner)
VisiGlide2™ straight tip
Arm D: Primary use of VisiGlide2™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide2™ (angled tip) resp. to VisiGlide1™ (tip according to the examiner)

Locations

Country Name City State
Germany Goethe University Hospital Frankfurt Frankfurt Hessen

Sponsors (4)

Lead Sponsor Collaborator
Johann Wolfgang Goethe University Hospital Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor, Klinikum Stadt Hanau, Robert Bosch Medical Center

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of successful passages of bilary (pancreatic) stenosis with the different guidewires. through study completion, an average of 2 years
Secondary Duration of ERCP session Comparison of time needed for the ERCP session in all study groups through study completion, an average of 2 years
See also
  Status Clinical Trial Phase
Completed NCT01525355 - EUS Prior to ERCP in the Positive Setting of Positive Intraoperative Cholangiogram (IOC) During Cholecystectomy N/A
Recruiting NCT05321472 - Artificial Intelligence-assisted Common Bile Duct Stent Selection in Endoscopic Retrograde Cholangiopancreatography